(a) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Deca | Questions | VH | H | M | L | VL | No. Resp. | Mean | Std | CNS | RANK (CONS) |
5 | 4 | 3 | 2 | 1 | |||||||
Environmental Matrix | |||||||||||
EM3 | Sediments | 2 | 13 | 5 | 3 | 0 | 23 | 3.61 | 0.69 | 0.71 | 25 |
EM4 | Sewage sludge | 2 | 12 | 7 | 2 | 0 | 23 | 3.61 | 0.84 | 0.73 | 20 |
EM5 | Soil | 3 | 9 | 7 | 4 | 0 | 23 | 3.48 | 0.78 | 0.66 | 39 |
Level of exposure | |||||||||||
EX2 | Occupationally exposed | 1 | 12 | 8 | 2 | 0 | 23 | 3.52 | 0.73 | 0.75 | 15 |
Main sources of exposure | |||||||||||
EX5 | Occupationally exposed | 3 | 13 | 6 | 1 | 0 | 23 | 3.78 | 0.74 | 0.77 | 12 |
Occupational exposed | |||||||||||
EX11 | Inhalation | 4 | 8 | 10 | 1 | 0 | 23 | 3.65 | 0.83 | 0.71 | 27 |
Infants and children | |||||||||||
EX17 | Via breast milk | 2 | 14 | 4 | 2 | 1 | 23 | 3.61 | 0.94 | 0.68 | 34 |
Toxicokinetics | |||||||||||
TK10 | Final metabolite concentration in target tissues | 0 | 1 | 3 | 10 | 9 | 23 | 1.83 | 0.83 | 0.73 | 22 |
Human Epidemiological studies | |||||||||||
TX01 | Males | 0 | 1 | 5 | 7 | 9 | 22 | 1.91 | 0.92 | 0.68 | 33 |
TX02 | Females | 0 | 1 | 4 | 7 | 10 | 22 | 1.82 | 0.91 | 0.69 | 32 |
Knowledge of the mechanisms of actions | |||||||||||
TX16 | Metabolites of BDE209 | 0 | 2 | 1 | 14 | 5 | 22 | 2.00 | 0.82 | 0.80 | 4 |
(b) | |||||||||||
Deca | Questions | VH | H | M | L | VL | No.Resp. | Mean | Std | CNS | RANK (CONS) |
5 | 4 | 3 | 2 | 1 | |||||||
Environmental Matrix | |||||||||||
EM6 | Water | 2 | 4 | 8 | 6 | 3 | 23 | 2.83 | 0.95 | 0.59 | 57 |
Level of exposure | |||||||||||
EX1 | The general population | 0 | 2 | 15 | 6 | 0 | 23 | 2.83 | 0.58 | 0.83 | 2 |
General population | |||||||||||
EX9 | Ingestion | 1 | 4 | 14 | 4 | 0 | 23 | 3.09 | 0.73 | 0.80 | 5 |
Occupational exposed | |||||||||||
EX10 | Direct contact dermal | 0 | 3 | 15 | 5 | 0 | 23 | 2.91 | 0.60 | 0.84 | 1 |
Toxicokinetics | |||||||||||
TK04 | Debrominated or metabolized by the intestinal microflora | 0 | 0 | 7 | 15 | 1 | 23 | 2.26 | 0.54 | 0.82 | 3 |
TK07 | Excreted via urine | 2 | 5 | 5 | 8 | 3 | 23 | 2.78 | 1.20 | 0.55 | 58 |
Neurodevelopment | |||||||||||
TX05 | Males exposed during fetal or neonatal life | 2 | 2 | 8 | 7 | 3 | 22 | 2.68 | 1.13 | 0.60 | 55 |
TX06 | Females exposed during fetal or neonatal life | 2 | 1 | 9 | 6 | 4 | 22 | 2.59 | 1.14 | 0.59 | 56 |
Reproductive function in | |||||||||||
TX13 | Males exposed during foetal or neonatal life | 1 | 3 | 7 | 7 | 4 | 22 | 2.55 | 1.10 | 0.60 | 53 |
TX14 | Females exposed during foetal or neonatal life | 1 | 3 | 7 | 7 | 4 | 22 | 2.55 | 1.10 | 0.60 | 54 |
Knowledge of the mechanisms of actions | |||||||||||
TX16 | Metabolites of BDE209 | 0 | 2 | 1 | 14 | 5 | 22 | 2.00 | 0.82 | 0.80 | 4 |